Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIT | P10721 | 8/20 | 0.81 |
| ▸ | SRC | P12931 | 1/20 | 0.61 |
| ▸ | ABL1 | P00519 | 7/20 | 0.60 |
| ▸ | BRAF | P15056 | 2/20 | 0.59 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.58 |
| ▸ | KDR | P35968 | 2/20 | 0.58 |
| ▸ | CSF1R | P07333 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17936186 | 0.90 | KIT (0.93) | KITABL1BRAFFGFR1KDR | |
| SCHEMBL30080773 | 0.90 | KIT (0.93) | KITABL1BRAFFGFR1KDR | |
| SCHEMBL4103102 | 0.90 | KIT (1.00) | KITABL1BRAFFGFR1KDR | |
| SCHEMBL29856181 | 0.90 | KIT (1.00) | KITABL1BRAFFGFR1KDR | |
| SCHEMBL16908401 | 0.87 | ABL1 (0.64) | KITSRCABL1FGFR1KDR | |
| SCHEMBL29674969 | 0.85 | KIT (0.80) | KITSRCABL1BRAF | |
| SCHEMBL16755287 | 0.85 | KIT (0.80) | KITSRCABL1BRAF | |
| SCHEMBL16755299 | 0.83 | KIT (0.87) | KITSRCABL1BRAFFGFR1 | |
| SCHEMBL30904911 | 0.82 | KIT (0.71) | KITSRCABL1BRAF | |
| SCHEMBL20912769 | 0.82 | KIT (0.71) | KITSRCABL1BRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9255107-B2 | Heteroaryl alkyne compound and use thereof | NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) | 2016-02-09 | — | — | US | disclosed |
| US-20150299202-A1 | HETEROARYL ALKYNE COMPOUND AND USE THEREOF | NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) | 2015-10-22 | — | — | US | disclosed |
| EP-2927232-A1 | HETEROARYL ALKYNE COMPOUND AND APPLICATION THEREOF | Nanjing Sanhome Pharmaceutical Co., Ltd. (CN) | 2015-10-07 | — | — | EP | disclosed |
| EP-2896620-A1 | ALKYNYL HETEROAROMATIC RING COMPOUND AND APPLICATION THEREOF | Nanjing Sanhome Pharmaceutical Co., Ltd. (CN) | 2015-07-22 | — | — | EP | disclosed |
| CN-104797581-A | HETEROARYL ALKYNE COMPOUND AND APPLICATION THEREOF | NANJING SANHOME PHARMACEUTICAL CO LTD | 2015-07-22 | — | — | CN | disclosed |
| US-20150152088-A1 | ALKYNYL HETEROAROMATIC COMPOUND AND USE THEREOF | NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) | 2015-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150299202-A1 | HETEROARYL ALKYNE COMPOUND AND USE THEREOF | ABL1, ALK, ABL2 | KIT 163/4885SRC 5/4885ABL1 1/4885 |
| US-20150152088-A1 | ALKYNYL HETEROAROMATIC COMPOUND AND USE THEREOF | ALK, CYP3A43, ALKBH3 | KIT 1066/4885SRC 210/4885ABL1 290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.